Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in your watchlist
Most Trending
+34.28%
+6.50%
-6.76%
+1.93%
+1.43%
PCVX
Vaxcyte
$42.66
Login to see Vaxcyte (PCVX) Stock IQ rating and get instant clarity on whether to Buy, Hold, or Avoid Technical Indicators
5+ Days Up
Chart
$32.72 (+30.38%)
$36.38 (+17.26%)
$29.11 (+46.55%)
$115.5 (-63.06%)
PCVX has Moderate Risk Level based on volatility, sector strength, volume, investor confidence, and outlook. Click here to check what is your level of risk
Risks Indicators
Beta greater than 1.0
PCVX overall standing based on key factors, offering insights into analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings
Rating
Rating
Momentum
Momentum
Activity
Activity
Future
Future
PCVX Analysts opinion is negative and it remained unchanged from the past 3 months
Analysts perspectives on the stock desirability, trend direction, and growth potential.
PCVX Street view is extremely bullish and have positive views on the near-term outlook
Average key support and resistance price levels.
Login to displayPCVX Earnings
The TTM reflects 12-month period, providing review of PCVX financial performance.
The company financial health is gradually deteriorating, indicating rising risks and weakening fundamentals
Financial Score
What is PCVX current stock price?
What are PCVX stock strengths?
What risks are associated with PCVX stock?
When is PCVX next earnings report?
What is PCVX market cap and volume?
What is PCVX's current Stock IQ?
Should I buy PCVX stock right now?
Is PCVX a Strong Buy right now?
What does a 'Strong Buy' rating mean for PCVX?
What does a 'Strong Sell' rating mean for PCVX?
What factors influence PCVX's Stock IQ?
FIND US ON
Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Stay ahead of the market
Market trends
Investment tips
Market analysis service
Future potential
Informed investment decisions
Investment analysis
IInvestment strategies
In-depth stock analysis
Performance analysis
Stock market insights
Financial trends analysis
Most Trending
+34.28%
+6.50%
-6.76%
+1.93%
+1.43%
PCVX
Vaxcyte
Current Price
$42.66
Stock Insights
Technical Indicators
5+ Days Up
Login to unlock Vaxcyte (PCVX) Stock IQ rating and get instant clarity on whether to Buy, Hold, or Avoid
Chart
$32.72 (+30.38%)
$36.38 (+17.26%)
$29.11 (+46.55%)
$115.5 (-63.06%)
PCVX Analysts Opinion
PCVX Overall standing by considering key factors, reflecting analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings
Rating
Rating
Momentum
Momentum
Activity
Activity
Future
Future
PCVX Analysts opinion is negative and it remained unchanged from the past 3 months
Analysts perspectives on the stock desirability, trend direction, and growth potential.
PCVX Street view is extremely bullish and have positive views on the near-term outlook
PCVX has Moderate Risk Level based on volatility, sector strength, volume, investor confidence, and outlook. Click here to check what is your level of risk
Risks Indicators
Beta greater than 1.0
Average key support and resistance price levels.
Login to displayPCVX Earnings
The TTM data reflects the most recent 12-month period, providing overview of PCVX financial performance.
PCVX Financial Health
The company financial health is gradually deteriorating, indicating rising risks and weakening fundamentals
Financial Score
PCVX Latest Analysis
Vaxcyte to Establish Fill-Finish Manufacturing in North Carolina as Key Element of Long-Term United States Commercial Supply Strategy Representing Up to $1 Billion in Manufacturing and Services. SAN CARLOS Calif. Sept. 30 2025 (GLOBE NEWSWIRE) -- Vaxcyte Inc. (NASDAQ:) a clinical-stage vaccine innovation company today announced a new agreement with Thermo Fisher Scientific Inc. the world leader in serving science to bring additional fill-finish commercial manufacturing for Vaxcyte'.s broad-s
Tue Sep 30, 2025
Vaxcyte teams up with Thermo Fisher to ensure future vaccine production.
Tue Sep 30, 2025
Vaxcyte Inc. (PCVX) Announces Progress in its VAX-31 Infant Vaccine Study. Vaxcyte Inc. (NASDAQ:PCVX) is one of the Oversold Growth Stocks to Buy According to Analysts. On September 3 Vaxcyte Inc. (NASDAQ:PCVX) announced progress in its VAX-31 infant vaccine study for Phase 2. The drug has moved to the third and final dose-finding study after protocol changes that added a new optimized dose arm and removed [….]
Tue Sep 30, 2025
FIND US ON
Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
PCVX Stock trends
PCVX Stock performance
PCVX Stock analysis
PCVX investment strategies
Disclaimer:
Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor.
The Readiness Indicators, Sentiment Indicators, and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses.
Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.
Overview
Trending
Screener
Insights
Top Rated
Momentum
Earnings